HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Are we improving the outcome for patients with T-cell prolymphocytic leukemia by allogeneic stem cell transplantation?

AuthorsMarco Herling
JournalEuropean journal of haematology (Eur J Haematol) Vol. 94 Issue 3 Pg. 191-2 (Mar 2015) ISSN: 1600-0609 [Electronic] England
PMID25712069 (Publication Type: Editorial)
Chemical References
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Alemtuzumab
Topics
  • Alemtuzumab
  • Antibodies, Monoclonal, Humanized (therapeutic use)
  • Antineoplastic Agents (therapeutic use)
  • Antineoplastic Combined Chemotherapy Protocols
  • Clinical Trials as Topic
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Leukemia, Prolymphocytic, T-Cell (drug therapy, mortality, pathology)
  • Survival Analysis
  • Transplantation, Autologous
  • Transplantation, Homologous
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: